Tricor (fenofibrate)

Abbott Laboratories

Approval Status
Approved February 1998

Treatment for
high triglyceride levels

Possible similar drugs

Cardiovascular / Cardiology

Tricor, a micronized form of the drug fenofibrate, has been approved for the treatment of very high triglyceride levels. Tricor is indicated as an adjunct to diet for the treatment of adults with very high serum triglyceride levels, specifically Types IV and V hyperlipidemia, who are not appropriately controlled by diet alone and are at risk of pancreatitis.

Tricor (fenofibrate) Drug Information

The Tricor (fenofibrate) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top